[Other]Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

Post time 3 day(s) ago

Assistant settings

journal：The Lancet

Authors：Adrianus Johannes de Langen, MD PhD Assist Prof Melissa L Johnson, MD Prof Julien Mazieres, MD PhD Prof Anne-Marie C Dingemans, MD PhD Giannis Mountzios, MD PhD Prof Miklos Pless, MD et al

Published date: MARCH 04, 202304, 2023

DOI：10.1016/S0140-6736(23)00221-0

Article link：https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00221-0/abstract

Post time 3 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] [Other]Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today